We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.88B
AUM Growth
-$312M
Cap. Flow
-$314M
Cap. Flow %
-16.69%
Top 10 Hldgs %
23.69%
Holding
207
New
35
Increased
64
Reduced
46
Closed
62

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$37.1M
2
CMCSA icon
Comcast
CMCSA
+$36.9M
3
ILMN icon
Illumina
ILMN
+$32.3M
4
C icon
Citigroup
C
+$29.7M
5
VTRS icon
Viatris
VTRS
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 20.32%
2 Consumer Discretionary 17.17%
3 Energy 12.32%
4 Healthcare 9.35%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SD icon
101
SandRidge Energy
SD
$531M
$4.31M 0.23%
296,130
-7,561
-2% -$102K
VYX icon
102
NCR Voyix
VYX
$1.09B
$4.31M 0.23%
+340,899
New +$4.91M
LRN icon
103
Stride
LRN
$3.33B
$4.27M 0.23%
67,739
+9,038
+15% +$545K
NVEI
104
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$4.21M 0.22%
133,273
-398,449
-75% -$10.1M
LEG icon
105
Leggett & Platt
LEG
$1.29B
$4.2M 0.22%
+219,455
New +$4.77M
RSKD icon
106
Riskified
RSKD
$712M
$4.13M 0.22%
763,203
+174,953
+30% +$831K
WCC
107
WESCO International
WCC
$17.9B
$3.95M 0.21%
+23,050
New +$3.81M
RGP icon
108
Resources Connection
RGP
$145M
$3.86M 0.21%
+292,948
New +$3.91M
UFI icon
109
UNIFI
UFI
$129M
$3.73M 0.2%
622,276
-191,477
-24% -$1.16M
CSTL icon
110
Castle Biosciences
CSTL
$988M
$3.69M 0.2%
166,714
-5,098
-3% -$111K
SEI
111
Solaris Energy Infrastructure
SEI
$3.86B
$3.6M 0.19%
+415,420
New +$3.26M
HURC icon
112
Hurco Companies Inc
HURC
$141M
$3.44M 0.18%
170,747
+75,527
+79% +$1.78M
NVCR icon
113
NovoCure
NVCR
$2.02B
$3.42M 0.18%
218,990
-214,961
-50% -$3.16M
SAMG icon
114
Silvercrest Asset Management
SAMG
$77.6M
$3.28M 0.17%
207,358
-58,182
-22% -$955K
VSH icon
115
Vishay Intertechnology
VSH
$5.08B
$3.05M 0.16%
+134,602
New +$3M
CMTL icon
116
Comtech Telecommunications
CMTL
$51.5M
$3.04M 0.16%
886,135
+697,248
+369% +$4.37M
PLOW icon
117
Douglas Dynamics
PLOW
$984M
$3.03M 0.16%
+125,683
New +$3.18M
TTEC icon
118
TTEC Holdings
TTEC
$113M
$2.91M 0.15%
+280,607
New +$4.7M
LXFR icon
119
Luxfer Holdings
LXFR
$457M
$2.84M 0.15%
+274,003
New +$2.45M
DOMO icon
120
Domo
DOMO
$189M
$2.83M 0.15%
316,964
+93,858
+42% +$975K
TDOC icon
121
Teladoc Health
TDOC
$1.29B
$2.82M 0.15%
+186,718
New +$3.39M
ADT icon
122
ADT
ADT
$5.49B
$2.77M 0.15%
411,522
-49,087
-11% -$326K
SLCA
123
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$2.54M 0.13%
+204,344
New +$2.29M
ATSG
124
DELISTED
Air Transport Services Group
ATSG
$2.49M 0.13%
+180,885
New +$2.61M
PRGO icon
125
Perrigo
PRGO
$1.75B
$2.42M 0.13%
+75,328
New +$2.38M

Similar funds

Invenomic Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Invenomic Capital Management held 207 positions worth $1.88B, down 14% from $2.19B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $314M in Q1 2024, closing 62 positions and reducing 46 holdings. Its most notable exit was QuidelOrtho, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Invenomic Capital Management opened a new position in Archer Daniels Midland worth $37.9M.

  • Invenomic Capital Management's largest Q1 2024 buy was Archer Daniels Midland: 603,681 shares worth $37.9M.
  • Invenomic Capital Management added most to 3M in Q1 2024, an estimated $23.6M increase.
  • Invenomic Capital Management's biggest Q1 2024 reduction was Illumina, cutting an estimated $32.3M.
  • Invenomic Capital Management fully exited QuidelOrtho in Q1 2024, selling an estimated $37.1M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.88B portfolio in Q1 2024.
  • Invenomic Capital Management opened 35 new positions and closed 62 in Q1 2024.
  • Invenomic Capital Management's portfolio value fell 14% quarter-over-quarter to $1.88B.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.